We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

FOR PREVIEW ONLY (Print)

Hyung L. Kim, MD

Director, Academic Urology Program

Associate Director, Surgical Research in the Samuel Oschin Comprehensive Cancer Institute

Medallion Group Chair in Urology

Co-Medical Director, Urologic Oncology Center

8635 W. Third St.
West Medical Office Tower, Suite 1070W
Los Angeles, CA 90048

Phone:

310-423-4700

Fax:

310-423-4711

Parking Instructions:

Parking is available in Lot 4. Validation will be provided only for this lot.

Hyung L. Kim, MD

Director, Academic Urology Program

Associate Director, Surgical Research in the Samuel Oschin Comprehensive Cancer Institute

Medallion Group Chair in Urology

Co-Medical Director, Urologic Oncology Center

  • Urology

Adrenal Gland Cancers

Adrenal Gland Disorders

Adrenalectomy (Adrenal Gland Removal)

Bladder Cancers

Cystectomy (Urinary Bladder Removal)

Kidney Cancers

Neobladder Surgery / Surgeries

Nephrectomy

Pheochromocytoma

Prostate Cancers

Robotic Cystectomy

Robotic Prostatectomy

Testicular Cancers

Ureteropelvic Junction Obstruction (UPJ)

Hyung L. Kim, MD, is director of the Cedars-Sinai Academic Urology Program and associate director of Surgical Research in the Samuel Oschin Comprehensive Cancer Center. He has two professional passions. A practicing urologic oncologist, Kim is devoted to promoting the physical and emotional health of his patients with cancers of the kidney, testis, prostate and bladder. His training includes fellowships in urologic oncology and minimally invasive surgery. He routinely provides treatments and second opinions for complex and difficult urologic cancer cases. Kim's second area of professional passion is his laboratory research, which has two areas of focus. The first area involves developing novel immune therapies for cancers. His lab is investigating the immune modulating effects of molecularly targeted therapies administered in combination with cancer vaccines. Heat shock protein-based cancer vaccines are used as model vaccines. Therapeutic goals include generating high-quality memory T cells and suppressing regulatory T cells. Kim's research also focuses on discovery and validation of clinically useful biomarkers for patients with urologic cancers. His laboratory has been developing new technology for generating multimarker expression profiles using archival tumors. His clinical work and research are highly complementary. Kim can offer his patients leading-edge treatment approaches, and the most challenging patient cases provide ideas and inspiration for his research.

  • Medical School: Pritzker School of Medicine, University of Chicago, 1996
  • Internship: University of Chicago Medical Center, 1998
  • Residency: University of Chicago Hospitals, 2002
  • Fellowship: David Geffen School of Medicine at UCLA, 2003
  • Fellowship: David Geffen School of Medicine at UCLA, 2004
  • Edwin Beer Award
  • American Urologic Association Surgeon Scientist Award
  • Endowment, Medallion Chair in Urology
  • Cancer and Leukemia Group B Junior Faculty Research Award

Click here for a list of peer-reviewed publications.

  • Li P, Conley A, Zhang H, Kim HL. Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq. BMC Genomics. 2014;15:1087.
  • Underwood W, Kim HL. Intermediate-term oncological efficacy of laparoscopic retroperitoneal lymph node dissection for non-seminomatous germ cell testicular cancer. BJU Int. 2012;109(2):281-285.
  • Hellenthal NJ, Underwood W, Penetrante R, Litwin A, Zhang S, Wilding GE, Teh BT, Kim HL. Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma. J Urol. 2010;184(3):859-864.
  • Kim HL, Puymon MR, Qin, M, Guru K, Mohler JL. A method for using life tables to estimate lifetime risk for prostate cancer death. J Natl Compr Canc Netw. 2010;8(2):148-154.
  • Guru KA, Sternberg K, Wilding GE, Tan W, Butt ZM, Mohler JL, Kim HL. The lymph node yield during robot-assisted radical cystectomy. BJU Int. 2008;102(2):231-234.

Show moreShow less

English / Korean

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or